NCT07048249 2026-03-18
Single Arm Romiplostim to Prevent CIT
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Recruiting
Clinical Trials
11 trialsNCT04671901 2025-05-28
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT04478123 2024-02-14
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04427306 2023-09-15
Neoadjuvant T-VEC in High Risk Early Melanoma
University of California, Davis
Phase 2 Suspended
NCT01516619 2022-08-12
ProRom
IRCCS San Raffaele
Phase 2 Completed
NCT00299182 2021-09-21
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02046291 2021-06-08
Safety of Romiplostim (Nplate®) Following UCBT
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT03622931 2021-02-08
TRACEII
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Phase 2 Terminated
NCT01676961 2018-10-15
Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy
NYU Langone Health
Phase 2 Terminated
NCT02227576 2018-04-25
PLATUM
University Hospital, Lille
Phase 2 Terminated
NCT00147225 2014-05-08
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
M.D. Anderson Cancer Center
Phase 1/2 Completed